The Importance of Early Diagnosis and Treatment in Rheumatic Diseases
Experts emphasized the critical role of early diagnosis and treatment in preventing loss of function in rheumatic diseases, while evaluating innovative approaches such as biosimilar drugs and artificial intelligence.
In statements made on the occasion of October 12 World Arthritis Day, the presidents of the Turkish Society for Rheumatology and EULAR stated that symptoms such as joint pain and morning stiffness should not be ignored, noting that early diagnosis and treatment can prevent permanent loss of function.
Symptoms should not be ignored
It was stated that symptoms such as prolonged joint pain, swelling, restricted movement, and morning stiffness should not be ignored. It was noted that early diagnosis and treatment in rheumatic diseases are of vital importance in preventing permanent loss of function.
Can be seen in any age group
It was conveyed that rheumatic diseases are not only seen in advanced ages but can appear in different periods ranging from childhood to advanced age. It was stated that there are more than 150 diseases that can cause joint and musculoskeletal system complaints.
The early arthritis period is critical
It was reported that not all symptoms may appear simultaneously in the initial period and patients can be monitored with early arthritis definitions. It was emphasized that this period is of great importance in terms of interventions aimed at preventing the progression of the disease.
Advantages of biosimilar drugs
It was stated that biological drugs are an important option for patients who do not get an adequate response to standard treatments. It was conveyed that biosimilar drugs can increase access to treatment provided they meet scientific and safety standards.
The role and limits of artificial intelligence
It was stated that artificial intelligence has started to be used in early diagnosis, patient screening, medical imaging, and treatment selection. It was emphasized that this technology should not replace physicians' clinical evaluations and should only be used as a supportive tool.